![PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database](https://i1.rgstatic.net/publication/341002310_Development_of_the_clinical_calculator_for_mortality_of_patients_with_metastatic_clear_cell_type_renal_cell_carcinoma_An_analysis_of_patients_from_Korean_Renal_Cancer_Study_Group_database/links/5ea9743b45851592d6a8a5df/largepreview.png)
PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
![Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images](https://www.mdpi.com/cancers/cancers-13-00011/article_deploy/html/images/cancers-13-00011-g001.png)
Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images
![Glenmark Pharma: Glenmark launches kidney cancer treatment drug in India priced 96% lower than innovator brand - The Economic Times Glenmark Pharma: Glenmark launches kidney cancer treatment drug in India priced 96% lower than innovator brand - The Economic Times](https://m.economictimes.com/thumb/msid-80969546,width-1200,height-900,resizemode-4,imgsize-185852/18.jpg)
Glenmark Pharma: Glenmark launches kidney cancer treatment drug in India priced 96% lower than innovator brand - The Economic Times
![Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores](https://www.mdpi.com/cancers/cancers-13-00844/article_deploy/html/images/cancers-13-00844-g003.png)
Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
![The effect of the papillary renal cell carcinoma subtype on oncological outcomes | Scientific Reports The effect of the papillary renal cell carcinoma subtype on oncological outcomes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-78174-9/MediaObjects/41598_2020_78174_Fig1_HTML.png)
The effect of the papillary renal cell carcinoma subtype on oncological outcomes | Scientific Reports
![Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy](https://pub.mdpi-res.com/cancers/cancers-14-03848/article_deploy/html/images/cancers-14-03848-g001.png?1660053841)
Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy
![Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-49250-6/MediaObjects/41598_2019_49250_Fig1_HTML.png)
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
![Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-49250-6/MediaObjects/41598_2019_49250_Fig2_HTML.png)
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
![Frontiers | Bone metastasis risk and prognosis assessment models for kidney cancer based on machine learning Frontiers | Bone metastasis risk and prognosis assessment models for kidney cancer based on machine learning](https://www.frontiersin.org/files/Articles/1015952/fpubh-10-1015952-HTML/image_m/fpubh-10-1015952-g001.jpg)